Invivyd, Inc. (IVVD)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

8 annual periodsNewest to oldest
20252024202320222021 · Dec 312021 · Sep 302021 · Jun 302021 · Mar 31
Revenue$53.4M$25.4M$0
Research & development$38.3M$137.3M$158.7M$179.2M$182.9M
Operating expenses$109.0M$202.3M$212.8M$248.0M$226.9M
Operating income−$55.6M−$176.9M−$212.8M−$248.0M−$226.9M
Net income−$52.5M−$169.9M−$198.6M−$241.3M−$226.8M−$143.7M−$83.4M−$38.7M
Basic EPSper diluted share-$0.30-$1.43-$1.81-$2.23-$5.32
Diluted EPSper diluted share-$0.30-$1.43-$1.81-$2.23-$5.32

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys1$125.0K disclosed value
Sells (SEC code S)35$1.36M disclosed value
36 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Feb 18, 2026Form 4 · 10b5-1Allen Robert D. IIIChief Scientific OfficerSellCommon Stock19.4K$1.58$30.6K114.5K
Feb 18, 2026Form 4 · 10b5-1Green JulieChief Human Resources OfficerSellCommon Stock21.0K$1.58$33.1K107.7K
Feb 18, 2026Form 4 · 10b5-1Duke William E.Chief Financial OfficerSellCommon Stock21.0K$1.58$33.1K107.7K
Feb 18, 2026Form 4 · 10b5-1Lee Timothy EdwardChief Commercial OfficerSellCommon Stock21.0K$1.58$33.1K117.7K
Feb 18, 2026Form 4 · 10b5-1Andersen JillChief Legal Officer, SecretarySellCommon Stock34.9K$1.58$55.2K181.7K